カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界の脂質注射薬市場2022年：イントラリピッド、リポシンIII、スモフリピッド、クリノリピッド、その他

◆英語タイトル：Global Lipid Injectable Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書（GIR22MY8879）◆商品コード：GIR22MY8879
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2022年5月（※2025年版があります。お問い合わせください。）
◆ページ数：92
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

脂質注射薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の脂質注射薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

脂質注射薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・イントラリピッド、リポシンIII、スモフリピッド、クリノリピッド、その他

用途別セグメントは次のように区分されます。
・痛み軽減、毒性軽減、標的化ドラッグデリバリー、その他

世界の脂質注射薬市場の主要な市場プレーヤーは以下のとおりです。
・Fresenius Kabi、Abbott Laboratories、Pfizer、B. Braun Melsungen AG、Heron Therapeutics Inc.、The Medicines Company (Novartis)、Baxter International Inc.

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、脂質注射薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な脂質注射薬メーカーの企業概要、2019年～2022年までの脂質注射薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な脂質注射薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別脂質注射薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの脂質注射薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での脂質注射薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および脂質注射薬の産業チェーンを掲載しています。
・第13、14、15章では、脂質注射薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Fresenius Kabi、Abbott Laboratories、Pfizer、B. Braun Melsungen AG、Heron Therapeutics Inc.、The Medicines Company (Novartis)、Baxter International Inc.
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：イントラリピッド、リポシンIII、スモフリピッド、クリノリピッド、その他
・用途別分析2017年-2028年：痛み軽減、毒性軽減、標的化ドラッグデリバリー、その他
・脂質注射薬の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・脂質注射薬のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・脂質注射薬のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・脂質注射薬の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・脂質注射薬の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Lipid Injectable Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Lipid Injectable Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Pain Reduction accounting for % of the Lipid Injectable Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Intralipid segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Lipid Injectable Drugs include Fresenius Kabi, Abbott Laboratories, Pfizer, B. Braun Melsungen AG, and Heron Therapeutics Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Lipid Injectable Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Intralipid
Liposyn III
Smoflipid
Clinolipid
Others
Market segment by Application can be divided into
Pain Reduction
Toxicity Reduction
Targeted Drug Delivery
Others
The key market players for global Lipid Injectable Drugs market are listed below:
Fresenius Kabi
Abbott Laboratories
Pfizer
B. Braun Melsungen AG
Heron Therapeutics Inc.
The Medicines Company (Novartis)
Baxter International Inc.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lipid Injectable Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Lipid Injectable Drugs, with price, sales, revenue and global market share of Lipid Injectable Drugs from 2019 to 2022.
Chapter 3, the Lipid Injectable Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lipid Injectable Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Lipid Injectable Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Lipid Injectable Drugs.
Chapter 13, 14, and 15, to describe Lipid Injectable Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Lipid Injectable Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Lipid Injectable Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Intralipid
1.2.3 Liposyn III
1.2.4 Smoflipid
1.2.5 Clinolipid
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Lipid Injectable Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Pain Reduction
1.3.3 Toxicity Reduction
1.3.4 Targeted Drug Delivery
1.3.5 Others
1.4 Global Lipid Injectable Drugs Market Size & Forecast
1.4.1 Global Lipid Injectable Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Lipid Injectable Drugs Sales in Volume (2017-2028)
1.4.3 Global Lipid Injectable Drugs Price (2017-2028)
1.5 Global Lipid Injectable Drugs Production Capacity Analysis
1.5.1 Global Lipid Injectable Drugs Total Production Capacity (2017-2028)
1.5.2 Global Lipid Injectable Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Lipid Injectable Drugs Market Drivers
1.6.2 Lipid Injectable Drugs Market Restraints
1.6.3 Lipid Injectable Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Fresenius Kabi
2.1.1 Fresenius Kabi Details
2.1.2 Fresenius Kabi Major Business
2.1.3 Fresenius Kabi Lipid Injectable Drugs Product and Services
2.1.4 Fresenius Kabi Lipid Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories Lipid Injectable Drugs Product and Services
2.2.4 Abbott Laboratories Lipid Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Lipid Injectable Drugs Product and Services
2.3.4 Pfizer Lipid Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 B. Braun Melsungen AG
2.4.1 B. Braun Melsungen AG Details
2.4.2 B. Braun Melsungen AG Major Business
2.4.3 B. Braun Melsungen AG Lipid Injectable Drugs Product and Services
2.4.4 B. Braun Melsungen AG Lipid Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Heron Therapeutics Inc.
2.5.1 Heron Therapeutics Inc. Details
2.5.2 Heron Therapeutics Inc. Major Business
2.5.3 Heron Therapeutics Inc. Lipid Injectable Drugs Product and Services
2.5.4 Heron Therapeutics Inc. Lipid Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 The Medicines Company (Novartis)
2.6.1 The Medicines Company (Novartis) Details
2.6.2 The Medicines Company (Novartis) Major Business
2.6.3 The Medicines Company (Novartis) Lipid Injectable Drugs Product and Services
2.6.4 The Medicines Company (Novartis) Lipid Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Baxter International Inc.
2.7.1 Baxter International Inc. Details
2.7.2 Baxter International Inc. Major Business
2.7.3 Baxter International Inc. Lipid Injectable Drugs Product and Services
2.7.4 Baxter International Inc. Lipid Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Lipid Injectable Drugs Breakdown Data by Manufacturer
3.1 Global Lipid Injectable Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Lipid Injectable Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Lipid Injectable Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Lipid Injectable Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Lipid Injectable Drugs Manufacturer Market Share in 2021
3.5 Global Lipid Injectable Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Lipid Injectable Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Lipid Injectable Drugs Market Size by Region
4.1.1 Global Lipid Injectable Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Lipid Injectable Drugs Revenue by Region (2017-2028)
4.2 North America Lipid Injectable Drugs Revenue (2017-2028)
4.3 Europe Lipid Injectable Drugs Revenue (2017-2028)
4.4 Asia-Pacific Lipid Injectable Drugs Revenue (2017-2028)
4.5 South America Lipid Injectable Drugs Revenue (2017-2028)
4.6 Middle East and Africa Lipid Injectable Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Lipid Injectable Drugs Sales in Volume by Type (2017-2028)
5.2 Global Lipid Injectable Drugs Revenue by Type (2017-2028)
5.3 Global Lipid Injectable Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Lipid Injectable Drugs Sales in Volume by Application (2017-2028)
6.2 Global Lipid Injectable Drugs Revenue by Application (2017-2028)
6.3 Global Lipid Injectable Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Lipid Injectable Drugs Sales by Type (2017-2028)
7.2 North America Lipid Injectable Drugs Sales by Application (2017-2028)
7.3 North America Lipid Injectable Drugs Market Size by Country
7.3.1 North America Lipid Injectable Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Lipid Injectable Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Lipid Injectable Drugs Sales by Type (2017-2028)
8.2 Europe Lipid Injectable Drugs Sales by Application (2017-2028)
8.3 Europe Lipid Injectable Drugs Market Size by Country
8.3.1 Europe Lipid Injectable Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Lipid Injectable Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Lipid Injectable Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Lipid Injectable Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Lipid Injectable Drugs Market Size by Region
9.3.1 Asia-Pacific Lipid Injectable Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Lipid Injectable Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Lipid Injectable Drugs Sales by Type (2017-2028)
10.2 South America Lipid Injectable Drugs Sales by Application (2017-2028)
10.3 South America Lipid Injectable Drugs Market Size by Country
10.3.1 South America Lipid Injectable Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Lipid Injectable Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Lipid Injectable Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Lipid Injectable Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Lipid Injectable Drugs Market Size by Country
11.3.1 Middle East & Africa Lipid Injectable Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Lipid Injectable Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Lipid Injectable Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Lipid Injectable Drugs
12.3 Lipid Injectable Drugs Production Process
12.4 Lipid Injectable Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Lipid Injectable Drugs Typical Distributors
13.3 Lipid Injectable Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Lipid Injectable Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Lipid Injectable Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 4. Fresenius Kabi Major Business
Table 5. Fresenius Kabi Lipid Injectable Drugs Product and Services
Table 6. Fresenius Kabi Lipid Injectable Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 8. Abbott Laboratories Major Business
Table 9. Abbott Laboratories Lipid Injectable Drugs Product and Services
Table 10. Abbott Laboratories Lipid Injectable Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Lipid Injectable Drugs Product and Services
Table 14. Pfizer Lipid Injectable Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. B. Braun Melsungen AG Basic Information, Manufacturing Base and Competitors
Table 16. B. Braun Melsungen AG Major Business
Table 17. B. Braun Melsungen AG Lipid Injectable Drugs Product and Services
Table 18. B. Braun Melsungen AG Lipid Injectable Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Heron Therapeutics Inc. Basic Information, Manufacturing Base and Competitors
Table 20. Heron Therapeutics Inc. Major Business
Table 21. Heron Therapeutics Inc. Lipid Injectable Drugs Product and Services
Table 22. Heron Therapeutics Inc. Lipid Injectable Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. The Medicines Company (Novartis) Basic Information, Manufacturing Base and Competitors
Table 24. The Medicines Company (Novartis) Major Business
Table 25. The Medicines Company (Novartis) Lipid Injectable Drugs Product and Services
Table 26. The Medicines Company (Novartis) Lipid Injectable Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Baxter International Inc. Basic Information, Manufacturing Base and Competitors
Table 28. Baxter International Inc. Major Business
Table 29. Baxter International Inc. Lipid Injectable Drugs Product and Services
Table 30. Baxter International Inc. Lipid Injectable Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global Lipid Injectable Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 32. Global Lipid Injectable Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 33. Market Position of Manufacturers in Lipid Injectable Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 34. Global Lipid Injectable Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Lipid Injectable Drugs Production Site of Key Manufacturer
Table 36. Lipid Injectable Drugs New Entrant and Capacity Expansion Plans
Table 37. Lipid Injectable Drugs Mergers & Acquisitions in the Past Five Years
Table 38. Global Lipid Injectable Drugs Sales by Region (2017-2022) & (K Units)
Table 39. Global Lipid Injectable Drugs Sales by Region (2023-2028) & (K Units)
Table 40. Global Lipid Injectable Drugs Revenue by Region (2017-2022) & (USD Million)
Table 41. Global Lipid Injectable Drugs Revenue by Region (2023-2028) & (USD Million)
Table 42. Global Lipid Injectable Drugs Sales by Type (2017-2022) & (K Units)
Table 43. Global Lipid Injectable Drugs Sales by Type (2023-2028) & (K Units)
Table 44. Global Lipid Injectable Drugs Revenue by Type (2017-2022) & (USD Million)
Table 45. Global Lipid Injectable Drugs Revenue by Type (2023-2028) & (USD Million)
Table 46. Global Lipid Injectable Drugs Price by Type (2017-2022) & (US$/Unit)
Table 47. Global Lipid Injectable Drugs Price by Type (2023-2028) & (US$/Unit)
Table 48. Global Lipid Injectable Drugs Sales by Application (2017-2022) & (K Units)
Table 49. Global Lipid Injectable Drugs Sales by Application (2023-2028) & (K Units)
Table 50. Global Lipid Injectable Drugs Revenue by Application (2017-2022) & (USD Million)
Table 51. Global Lipid Injectable Drugs Revenue by Application (2023-2028) & (USD Million)
Table 52. Global Lipid Injectable Drugs Price by Application (2017-2022) & (US$/Unit)
Table 53. Global Lipid Injectable Drugs Price by Application (2023-2028) & (US$/Unit)
Table 54. North America Lipid Injectable Drugs Sales by Country (2017-2022) & (K Units)
Table 55. North America Lipid Injectable Drugs Sales by Country (2023-2028) & (K Units)
Table 56. North America Lipid Injectable Drugs Revenue by Country (2017-2022) & (USD Million)
Table 57. North America Lipid Injectable Drugs Revenue by Country (2023-2028) & (USD Million)
Table 58. North America Lipid Injectable Drugs Sales by Type (2017-2022) & (K Units)
Table 59. North America Lipid Injectable Drugs Sales by Type (2023-2028) & (K Units)
Table 60. North America Lipid Injectable Drugs Sales by Application (2017-2022) & (K Units)
Table 61. North America Lipid Injectable Drugs Sales by Application (2023-2028) & (K Units)
Table 62. Europe Lipid Injectable Drugs Sales by Country (2017-2022) & (K Units)
Table 63. Europe Lipid Injectable Drugs Sales by Country (2023-2028) & (K Units)
Table 64. Europe Lipid Injectable Drugs Revenue by Country (2017-2022) & (USD Million)
Table 65. Europe Lipid Injectable Drugs Revenue by Country (2023-2028) & (USD Million)
Table 66. Europe Lipid Injectable Drugs Sales by Type (2017-2022) & (K Units)
Table 67. Europe Lipid Injectable Drugs Sales by Type (2023-2028) & (K Units)
Table 68. Europe Lipid Injectable Drugs Sales by Application (2017-2022) & (K Units)
Table 69. Europe Lipid Injectable Drugs Sales by Application (2023-2028) & (K Units)
Table 70. Asia-Pacific Lipid Injectable Drugs Sales by Region (2017-2022) & (K Units)
Table 71. Asia-Pacific Lipid Injectable Drugs Sales by Region (2023-2028) & (K Units)
Table 72. Asia-Pacific Lipid Injectable Drugs Revenue by Region (2017-2022) & (USD Million)
Table 73. Asia-Pacific Lipid Injectable Drugs Revenue by Region (2023-2028) & (USD Million)
Table 74. Asia-Pacific Lipid Injectable Drugs Sales by Type (2017-2022) & (K Units)
Table 75. Asia-Pacific Lipid Injectable Drugs Sales by Type (2023-2028) & (K Units)
Table 76. Asia-Pacific Lipid Injectable Drugs Sales by Application (2017-2022) & (K Units)
Table 77. Asia-Pacific Lipid Injectable Drugs Sales by Application (2023-2028) & (K Units)
Table 78. South America Lipid Injectable Drugs Sales by Country (2017-2022) & (K Units)
Table 79. South America Lipid Injectable Drugs Sales by Country (2023-2028) & (K Units)
Table 80. South America Lipid Injectable Drugs Revenue by Country (2017-2022) & (USD Million)
Table 81. South America Lipid Injectable Drugs Revenue by Country (2023-2028) & (USD Million)
Table 82. South America Lipid Injectable Drugs Sales by Type (2017-2022) & (K Units)
Table 83. South America Lipid Injectable Drugs Sales by Type (2023-2028) & (K Units)
Table 84. South America Lipid Injectable Drugs Sales by Application (2017-2022) & (K Units)
Table 85. South America Lipid Injectable Drugs Sales by Application (2023-2028) & (K Units)
Table 86. Middle East & Africa Lipid Injectable Drugs Sales by Region (2017-2022) & (K Units)
Table 87. Middle East & Africa Lipid Injectable Drugs Sales by Region (2023-2028) & (K Units)
Table 88. Middle East & Africa Lipid Injectable Drugs Revenue by Region (2017-2022) & (USD Million)
Table 89. Middle East & Africa Lipid Injectable Drugs Revenue by Region (2023-2028) & (USD Million)
Table 90. Middle East & Africa Lipid Injectable Drugs Sales by Type (2017-2022) & (K Units)
Table 91. Middle East & Africa Lipid Injectable Drugs Sales by Type (2023-2028) & (K Units)
Table 92. Middle East & Africa Lipid Injectable Drugs Sales by Application (2017-2022) & (K Units)
Table 93. Middle East & Africa Lipid Injectable Drugs Sales by Application (2023-2028) & (K Units)
Table 94. Lipid Injectable Drugs Raw Material
Table 95. Key Manufacturers of Lipid Injectable Drugs Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Lipid Injectable Drugs Typical Distributors
Table 99. Lipid Injectable Drugs Typical Customers
List of Figures
Figure 1. Lipid Injectable Drugs Picture
Figure 2. Global Lipid Injectable Drugs Revenue Market Share by Type in 2021
Figure 3. Intralipid
Figure 4. Liposyn III
Figure 5. Smoflipid
Figure 6. Clinolipid
Figure 7. Others
Figure 8. Global Lipid Injectable Drugs Revenue Market Share by Application in 2021
Figure 9. Pain Reduction
Figure 10. Toxicity Reduction
Figure 11. Targeted Drug Delivery
Figure 12. Others
Figure 13. Global Lipid Injectable Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 14. Global Lipid Injectable Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Lipid Injectable Drugs Sales (2017-2028) & (K Units)
Figure 16. Global Lipid Injectable Drugs Price (2017-2028) & (US$/Unit)
Figure 17. Global Lipid Injectable Drugs Production Capacity (2017-2028) & (K Units)
Figure 18. Global Lipid Injectable Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. Lipid Injectable Drugs Market Drivers
Figure 20. Lipid Injectable Drugs Market Restraints
Figure 21. Lipid Injectable Drugs Market Trends
Figure 22. Global Lipid Injectable Drugs Sales Market Share by Manufacturer in 2021
Figure 23. Global Lipid Injectable Drugs Revenue Market Share by Manufacturer in 2021
Figure 24. Lipid Injectable Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 Lipid Injectable Drugs Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 Lipid Injectable Drugs Manufacturer (Revenue) Market Share in 2021
Figure 27. Global Lipid Injectable Drugs Sales Market Share by Region (2017-2028)
Figure 28. Global Lipid Injectable Drugs Revenue Market Share by Region (2017-2028)
Figure 29. North America Lipid Injectable Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Europe Lipid Injectable Drugs Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific Lipid Injectable Drugs Revenue (2017-2028) & (USD Million)
Figure 32. South America Lipid Injectable Drugs Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa Lipid Injectable Drugs Revenue (2017-2028) & (USD Million)
Figure 34. Global Lipid Injectable Drugs Sales Market Share by Type (2017-2028)
Figure 35. Global Lipid Injectable Drugs Revenue Market Share by Type (2017-2028)
Figure 36. Global Lipid Injectable Drugs Price by Type (2017-2028) & (US$/Unit)
Figure 37. Global Lipid Injectable Drugs Sales Market Share by Application (2017-2028)
Figure 38. Global Lipid Injectable Drugs Revenue Market Share by Application (2017-2028)
Figure 39. Global Lipid Injectable Drugs Price by Application (2017-2028) & (US$/Unit)
Figure 40. North America Lipid Injectable Drugs Sales Market Share by Type (2017-2028)
Figure 41. North America Lipid Injectable Drugs Sales Market Share by Application (2017-2028)
Figure 42. North America Lipid Injectable Drugs Sales Market Share by Country (2017-2028)
Figure 43. North America Lipid Injectable Drugs Revenue Market Share by Country (2017-2028)
Figure 44. United States Lipid Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Lipid Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Lipid Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Lipid Injectable Drugs Sales Market Share by Type (2017-2028)
Figure 48. Europe Lipid Injectable Drugs Sales Market Share by Application (2017-2028)
Figure 49. Europe Lipid Injectable Drugs Sales Market Share by Country (2017-2028)
Figure 50. Europe Lipid Injectable Drugs Revenue Market Share by Country (2017-2028)
Figure 51. Germany Lipid Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Lipid Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Lipid Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Lipid Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Lipid Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Lipid Injectable Drugs Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Lipid Injectable Drugs Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Lipid Injectable Drugs Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Lipid Injectable Drugs Revenue Market Share by Region (2017-2028)
Figure 60. China Lipid Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Lipid Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea Lipid Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Lipid Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Lipid Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Lipid Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Lipid Injectable Drugs Sales Market Share by Type (2017-2028)
Figure 67. South America Lipid Injectable Drugs Sales Market Share by Application (2017-2028)
Figure 68. South America Lipid Injectable Drugs Sales Market Share by Country (2017-2028)
Figure 69. South America Lipid Injectable Drugs Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Lipid Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Lipid Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa Lipid Injectable Drugs Sales Market Share by Type (2017-2028)
Figure 73. Middle East & Africa Lipid Injectable Drugs Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa Lipid Injectable Drugs Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa Lipid Injectable Drugs Revenue Market Share by Region (2017-2028)
Figure 76. Turkey Lipid Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt Lipid Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Lipid Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa Lipid Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of Lipid Injectable Drugs in 2021
Figure 81. Manufacturing Process Analysis of Lipid Injectable Drugs
Figure 82. Lipid Injectable Drugs Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の脂質注射薬市場2022年：イントラリピッド、リポシンIII、スモフリピッド、クリノリピッド、その他(Global Lipid Injectable Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 脂質原料のグローバル市場展望 2023年-2029年：植物性、動物性
  • 世界の脂質分析装置市場インサイト及び予測（手持型脂質分析装置、卓上型脂質分析装置）
  • 世界の蛍光脂質プローブ市場インサイト及び予測（純度98％以上、純度98％以下）
  • 世界の家庭用自己注射装置市場2022年：使い捨て製品、非使い捨て製品
  • 世界のアトピー性皮膚炎治療薬市場2022年：注射剤、経口剤、熱帯剤